文献速递前列腺癌

前列腺癌中的自然杀伤细胞浸润预示患者结局改善

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-02-28

研究对包含45种癌症类型(全部癌症N=90,916,前列腺癌N=3365)的肿瘤样本进行DNA和RNA测序,用quanTIseq推断NK细胞浸润比例。结果显示NK细胞占细胞浸润中位数2-9%,高NK细胞浸润与45种癌症中28种(含前列腺癌)的OS改善相关,且与原发前列腺活检中常见驱动突变和AR-V7负相关。

要点

  • NK细胞占全部肿瘤细胞浸润的中位比例为2-9%。
  • 高NK细胞浸润与45种癌症中28种(含前列腺癌)的OS改善相关。
  • 原发前列腺活检中NK细胞浸润与常见驱动突变及AR-V7负相关。

核心结论

  • NK细胞可浸润包括原发性和转移性前列腺癌在内的广泛肿瘤,NK细胞浸润与前列腺癌患者结局改善相关。

研究设计与样本

  • 对提交至Caris Life Sciences的45种癌症类型肿瘤样本进行DNA(靶向/全外显子)和RNA(全转录组)测序,全部癌症N=90,916,前列腺癌N=3365,用quanTIseq从RNA-seq数据推断NK细胞分数和免疫解卷积,并计算真实世界总生存(OS)的Kaplan-Meier估计。

主要发现

  • NK细胞占全部细胞浸润的中位范围为2-9%。
  • 高NK细胞浸润与45种癌症类型中28种的OS改善相关,包括前列腺癌。
  • 在原发前列腺活检中,NK细胞浸润与常见驱动突变和雄激素受体变体(AR-V7)负相关,而与负性免疫调节因子正相关。
  • 较高水平的NK细胞浸润与符合代偿性抗炎反应的模式相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Natural killer (NK) cells are non-antigen specific innate immune cells that can be redirected to targets of interest using multiple strategies, although none are currently FDA-approved. We sought to evaluate NK cell infiltration into tumors to develop an improved understanding of which histologies may be most amenable to NK cell-based therapies currently in the developmental pipeline. METHODS: DNA (targeted/whole-exome) and RNA (whole-transcriptome) sequencing was performed from tumors from 45 cancer types (N = 90,916 for all cancers and N = 3365 for prostate cancer) submitted to Caris Life Sciences. NK cell fractions and immune deconvolution were inferred from RNA-seq data using quanTIseq. Real-world overall survival (OS) and treatment status was determined and Kaplan-Meier estimates were calculated. Statistical significance was determined using X2 and Mann-Whitney U tests, with corrections for multiple comparisons where appropriate. RESULTS: In both a pan-tumor and prostate cancer (PCa) -specific setting, we demonstrated that NK cells represent a substantial proportion of the total cellular infiltrate (median range 2-9% for all tumors). Higher NK cell infiltration was associated with improved OS in 28 of 45 cancer types, including (PCa). NK cell infiltration was negatively correlated with common driver mutations and androgen receptor variants (AR-V7) in primary prostate biopsies, while positively correlated with negative immune regulators. Higher levels of NK cell infiltration were associated with patterns consistent with a compensatory anti-inflammatory response. CONCLUSIONS: Using the largest available dataset to date, we demonstrated that NK cells infiltrate a broad range of tumors, including both primary and metastatic PCa. NK cell infiltration is associated with improved PCa patient outcomes. This study demonstrates that NK cells are capable of trafficking to both primary and metastatic PCa and are a viable option for immunotherapy approaches moving forward. Future development of strategies to enhance tumor-infiltrating NK cell-mediated cytolytic activity and activation while limiting inhibitory pathways will be key.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Zorko NA, Makovec A, Elliott A, et al. Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate Cancer Prostatic Dis. 2024. PMID: 38418892. doi:10.1038/s41391-024-00797-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。